Canada Pension Plan Investment Board
MIRM icon

Canada Pension Plan Investment Board’s Mirum Pharmaceuticals MIRM Stock Holding History

Canada Pension Plan Investment Board’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-8,800
Closed -$813K – 1801
2026
Q1 		$813K Sell
8,800
-24,896
-74% -$2.34M ﹤0.01% 1067
2025
Q4 		$2.66M Buy
33,696
+13,000
+63% +$933K ﹤0.01% 887
2025
Q3 		$1.52M Buy
+20,696
New +$1.32M ﹤0.01% 958
2025
Q1 		– Sell
-41,800
Closed -$1.73M – 1414
2024
Q4 		$1.73M Buy
+41,800
New +$1.74M ﹤0.01% 906

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Canada Pension Plan Investment Board's MIRM Position: Q2 2026 in Review

Canada Pension Plan Investment Board sold out of Mirum Pharmaceuticals (MIRM) in Q2 2026, closing a stake of 8,800 shares — an estimated $813K sold.

Canada Pension Plan Investment Board first reported a position in MIRM in Q4 2024 and held it in 4 quarters. The position peaked at $2.66M in Q4 2025. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Canada Pension Plan Investment Board reported no remaining Mirum Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 8,800 Mirum Pharmaceuticals shares in Q2 2026, an estimated $813K.
  • Canada Pension Plan Investment Board first reported a position in Mirum Pharmaceuticals in Q4 2024 and held it in 4 quarters.
  • Canada Pension Plan Investment Board's Mirum Pharmaceuticals position peaked at $2.66M in Q4 2025.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.